CRA’s Walter Colasante, Pascale Diesel, and Lev Gerlovin recently published a series of three articles in Cell & Gene on emerging gene and cell therapies and their impact on the market. Read the full series below.
How are cell and gene therapies changing drug development models?
New approaches to market access and reimbursement for gene and cell therapies
Four emerging commercialization strategies for gene and cell therapies
12 CRA consultants named top IP professionals in the 2021 IAM Patent 1000
12 CRA consultants were recognized as leading patent professionals by Intellectual Asset Management (IAM). The IAM Patent 1000 names the best-in-class patent...